NOAEL Studies
Cosmetic Ingredient
HC Red No. 14 NOAEL Studies
INCI: HC RED NO. 14
CAS: 99788-75-7
Raw No Observed Adverse Effect Level endpoint records grouped by source. This page does not render calculated Margin of Safety values.
COSMOS DB 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| COSMOS DB | LOAEL | 50 | mg/kg bw/day | rat | oral | 90 day | Subchronic | SCCS; C. Fabreguettes. IMEXINE BJ : 13-Week Toxicity Study by Oral Route in Rats, followed by a 4-week Recovery Period. CIT Study N° 13425 TCR, |
SCCNFP Opinion 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCNFP Opinion | NOAEL | =1000 | mg/kg/day | - | dermal | 4 weeks | repeated dose toxicity | Ref. : 5 2, p.7 |
SCCS Opinion 5 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| SCCS Opinion | NOAEL | =0.0008 | mg/kg bw | rat | oral | 13-week | dermal absorption | p.25 |
| SCCS Opinion | NOAEL | =50 | % | rat | oral | 13-week | dermal absorption | p.25 |
| SCCS Opinion | NOAEL | =500 | mg/kg bw/d | rat | oral | 13-week | dermal absorption | p.25 |
| SCCS Opinion | NOAEL | =1000 | mg/kg bw/day | - | - | 4 weeks | genotoxicity | p.17 |
| SCCS Opinion | NOAEL | =1000 | mg/kg bw/d | rat | oral | 13-week | dermal absorption | p.25 |
Regulatory source 10 endpoints
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| Regulatory source | developmental toxicity | 1000 | mg/kg/day | human | - | - | developmental toxicity | p.10 |
| Regulatory source | developmental toxicity | 1000 | mg/kg/day | rat | oral | 13-week | developmental toxicity | p.16 |
| Regulatory source | repeated dose toxicity | 1000 | mg/kg/day | - | dermal | 4 weeks | repeated dose toxicity | p.7 |
| Regulatory source | dermal absorption | =0.0008 | mg/kg bw | rat | oral | 13-week | dermal absorption | p.25 |
| Regulatory source | dermal absorption | 50 | % | rat | oral | 13-week | dermal absorption | p.25 |
| Regulatory source | dermal absorption | =500 | mg/kg bw/d | rat | oral | 13-week | dermal absorption | p.25 |
| Regulatory source | dermal absorption | =1000 | mg/kg bw/d | rat | oral | 13-week | dermal absorption | p.25 |
| Regulatory source | developmental toxicity | 1000 | mg/kg bw/day | - | - | - | developmental toxicity | p.24 |
| Regulatory source | developmental toxicity | 1000 | mg/kg bw/day | rat | oral | 13-week | developmental toxicity | p.26 |
| Regulatory source | genotoxicity | 1000 | mg/kg bw/day | - | - | 4 weeks | genotoxicity | p.17 |
openFDA substances 1 endpoint
| Source | Endpoint Type | Value | Unit | Species | Route | Duration | Study Type | Reference |
|---|---|---|---|---|---|---|---|---|
| openFDA substances | FDA UNII substance identifier | UVQ553995F | UNII | - | - | - | chemical | - |